Extraction schema:
{"type": "object", "properties": {"filer_name": {"type": "string", "description": "Registrant name (e.g., 'VANGUARD INDEX FUNDS'). The legal entity that files; one CIK can host multiple Series."}, "filer_lei": {"type": ["string", "null"], "description": "Registrant LEI, 20 hex characters (Legal Entity Identifier). 'N/A' is a valid value when the registrant has no LEI."}, "series_id": {"type": ["string", "null"], "description": "SEC-assigned Series identifier of the form Sxxxxxxxxx (10 chars). One Registrant can host many Series; this disambiguates the specific fund."}, "series_name": {"type": ["string", "null"], "description": "Human-readable name of the Series, e.g. 'VANGUARD TOTAL STOCK MARKET INDEX FUND'."}, "fund_lei": {"type": ["string", "null"], "description": "LEI of the Series (the actual fund)."}, "report_period_end": {"type": "string", "description": "Period of report, ISO date YYYY-MM-DD. Always a fiscal-quarter-end date because only the third month of each fiscal quarter is publicly disseminated."}, "total_assets_usd": {"type": "number", "description": "Total fund assets in USD, as a non-negative decimal."}, "total_liabilities_usd": {"type": ["number", "null"], "description": "Total fund liabilities in USD. Output null when the cover page does not state this."}, "net_assets_usd": {"type": "number", "description": "Total fund net assets in USD (assets minus liabilities)."}, "holdings": {"type": "array", "description": "Schedule of investments: every position held by the fund as of report_period_end. Order is filer-defined and not significant for grading.", "items": {"type": "object", "properties": {"issuer_name": {"type": "string", "description": "Issuer of the security. Verbatim as filed (e.g. 'Surgery Partners Inc')."}, "issuer_lei": {"type": ["string", "null"], "description": "Issuer LEI (20 chars) or 'N/A'. Required to be present in the XML even if 'N/A'."}, "security_title": {"type": "string", "description": "Title of the issue, e.g. 'SURGERY PARTNERS' or 'TREASURY BILL 01/26 0.00000'. May differ from issuer_name (e.g. issuer 'United States Govt' / title 'Treasury Bill ...')."}, "cusip": {"type": ["string", "null"], "description": "9-character CUSIP, uppercase. 'N/A' is permitted (foreign issuers without CUSIP). Compare case-insensitively."}, "isin": {"type": ["string", "null"], "description": "12-character ISIN if present in the identifiers block. Optional alternative when CUSIP is 'N/A'."}, "ticker": {"type": ["string", "null"], "description": "Equity ticker if present in the identifiers block."}, "balance": {"type": "number", "description": "Position size as a decimal. Interpreted via units: NS=number of shares, PA=principal amount, OU=other units."}, "units": {"type": "string", "enum": ["NS", "PA", "OU"], "description": "NS=number of shares, PA=principal amount, OU=other units (then descOthUnits is set). Equity positions almost always NS; debt almost always PA."}, "currency_code": {"type": ["string", "null"], "description": "ISO 4217 currency code of the position (USD, EUR, GBP, ...). Most fund holdings are reported in USD even when the underlying is foreign-denominated; non-USD positions also carry an exchange rate. Output null when the row does not state a currency code."}, "value_usd": {"type": "number", "description": "Position value in USD, decimal. PDF rendering may show with $ and commas; comparator must normalize."}, "percent_of_net_assets": {"type": "number", "description": "Percent of net assets, stored as a percent value (not a fraction). E.g. 1.156308 means 1.156% (filer's $15.26M position in $1.32B net assets). Filers report to 4-6 decimals; tiny positions can read like 0.001840 = 0.0018%."}, "payoff_profile": {"type": "string", "enum": ["Long", "Short", "N/A"], "description": "Direction of economic exposure."}, "asset_category": {"type": "string", "enum": ["EC", "EP", "DBT", "ABS", "STIV", "RA", "RB", "DCO", "DFE", "DFW", "DIR", "DOP", "DSW", "DSO", "DCR", "OTH", "LON"], "description": "Asset class. EC=equity-common, EP=equity-preferred, DBT=debt, ABS=asset-backed, STIV=short-term investment vehicle, RA=repurchase agreement, etc. Most enterprise-relevant filings will see EC, DBT, STIV, ABS predominantly."}, "issuer_category": {"type": ["string", "null"], "description": "Issuer class (CORP, MUN, USGSE, UST, RF, PF, OTHER). May be empty for certain instrument types."}, "investment_country": {"type": "string", "description": "ISO country code of the investment (US, GB, JP, ...)."}, "is_restricted": {"type": "string", "enum": ["Y", "N"], "description": "Restricted security flag (Rule 144 / private placement)."}, "fair_value_level": {"type": "string", "enum": ["1", "2", "3", "N/A"], "description": "US GAAP ASC 820 fair-value hierarchy. 1=quoted-active-market, 2=other-observable, 3=unobservable, N/A=not applicable."}}, "required": ["issuer_name", "issuer_lei", "security_title", "cusip", "balance", "units", "value_usd", "percent_of_net_assets", "payoff_profile", "asset_category", "investment_country", "is_restricted", "fair_value_level"]}}}, "required": ["filer_name", "report_period_end", "total_assets_usd", "net_assets_usd", "holdings"]}

Expected output:
{"filer_name": "Oak Associates Funds", "filer_lei": null, "series_id": "S000006542", "series_name": "LIVE OAK HEALTH SCIENCES FUND", "fund_lei": null, "report_period_end": "2026-10-31", "total_assets_usd": 52656146.98, "total_liabilities_usd": 45846.45, "net_assets_usd": 52610300.53, "holdings": [{"issuer_name": "Cencora Inc", "issuer_lei": "AI8GXW8LG5WK7E9UD086", "security_title": "Cencora, Inc.", "cusip": "03073E105", "isin": "US03073E1055", "ticker": null, "balance": 8034.0, "units": "NS", "currency_code": "USD", "value_usd": 2885973.48, "percent_of_net_assets": 5.4856, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Amgen Inc.", "issuer_lei": "62QBXGPJ34PQ72Z12S66", "security_title": "Amgen, Inc.", "cusip": "031162100", "isin": "US0311621009", "ticker": null, "balance": 7077.0, "units": "NS", "currency_code": "USD", "value_usd": 2419484.76, "percent_of_net_assets": 4.5989, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Elevance Health Inc.", "issuer_lei": "8MYN82XMYQH89CTMTH67", "security_title": "Elevance Health, Inc.", "cusip": "036752103", "isin": "US0367521038", "ticker": null, "balance": 3831.0, "units": "NS", "currency_code": "USD", "value_usd": 1324529.94, "percent_of_net_assets": 2.5176, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "The Cigna Group", "issuer_lei": "549300VIWYMSIGT1U456", "security_title": "Cigna Group (The)", "cusip": "125523100", "isin": "US1255231003", "ticker": null, "balance": 6051.0, "units": "NS", "currency_code": "USD", "value_usd": 1658639.61, "percent_of_net_assets": 3.1527, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Cardinal Health, Inc.", "issuer_lei": "CCU46N3GJMF4OK4N7U60", "security_title": "Cardinal Health, Inc.", "cusip": "14149Y108", "isin": "US14149Y1082", "ticker": null, "balance": 14297.0, "units": "NS", "currency_code": "USD", "value_usd": 3072139.36, "percent_of_net_assets": 5.8394, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Ensign Group Inc", "issuer_lei": "5493003K4HEEA8Q0BC72", "security_title": "Ensign Group, Inc. (The)", "cusip": "29358P101", "isin": "US29358P1012", "ticker": null, "balance": 3141.0, "units": "NS", "currency_code": "USD", "value_usd": 539184.06, "percent_of_net_assets": 1.0249, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Exelixis, Inc.", "issuer_lei": "254900PJQB59O2O95R37", "security_title": "Exelixis, Inc.", "cusip": "30161Q104", "isin": "US30161Q1040", "ticker": null, "balance": 52445.0, "units": "NS", "currency_code": "USD", "value_usd": 2169125.2, "percent_of_net_assets": 4.123, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Gilead Sciences Inc.", "issuer_lei": "549300WTZWR07K8MNV44", "security_title": "Gilead Sciences, Inc.", "cusip": "375558103", "isin": "US3755581036", "ticker": null, "balance": 13391.0, "units": "NS", "currency_code": "USD", "value_usd": 1900852.45, "percent_of_net_assets": 3.6131, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Incyte Corporation.", "issuer_lei": "549300Z4WN6JVZ3T4680", "security_title": "Incyte Corporation", "cusip": "45337C102", "isin": "US45337C1027", "ticker": null, "balance": 15511.0, "units": "NS", "currency_code": "USD", "value_usd": 1552185.77, "percent_of_net_assets": 2.9503, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Intuitive Surgical Inc.", "issuer_lei": "54930052SRG011710797", "security_title": "Intuitive Surgical, Inc.", "cusip": "46120E602", "isin": "US46120E6023", "ticker": null, "balance": 3517.0, "units": "NS", "currency_code": "USD", "value_usd": 1773341.74, "percent_of_net_assets": 3.3707, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "IQVIA Holdings Inc.", "issuer_lei": "549300W3R20NM4KQPH86", "security_title": "IQVIA Holdings, Inc.", "cusip": "46266C105", "isin": "US46266C1053", "ticker": null, "balance": 6398.0, "units": "NS", "currency_code": "USD", "value_usd": 1472499.7, "percent_of_net_assets": 2.7989, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Johnson & Johnson", "issuer_lei": "549300G0CFPGEF6X2043", "security_title": "Johnson & Johnson", "cusip": "478160104", "isin": "US4781601046", "ticker": null, "balance": 8261.0, "units": "NS", "currency_code": "USD", "value_usd": 1877312.25, "percent_of_net_assets": 3.5683, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Labcorp Holdings Inc", "issuer_lei": "N/A", "security_title": "Labcorp Holdings, Inc.", "cusip": "504922105", "isin": "US5049221055", "ticker": null, "balance": 4153.0, "units": "NS", "currency_code": "USD", "value_usd": 1127622.56, "percent_of_net_assets": 2.1433, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Lantheus Holdings Inc", "issuer_lei": "5299005HUB5IOJGO7S39", "security_title": "Lantheus Holdings, Inc.", "cusip": "516544103", "isin": "US5165441032", "ticker": null, "balance": 26355.0, "units": "NS", "currency_code": "USD", "value_usd": 1763676.6, "percent_of_net_assets": 3.3523, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Eli Lilly & Co.", "issuer_lei": "FRDRIPF3EKNDJ2CQJL29", "security_title": "Eli Lilly & Company", "cusip": "532457108", "isin": "US5324571083", "ticker": null, "balance": 970.0, "units": "NS", "currency_code": "USD", "value_usd": 1006035.5, "percent_of_net_assets": 1.9122, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Mckesson Corp.", "issuer_lei": "549300WZWOM80UCFSF54", "security_title": "McKesson Corporation", "cusip": "58155Q103", "isin": "US58155Q1031", "ticker": null, "balance": 2973.0, "units": "NS", "currency_code": "USD", "value_usd": 2471187.33, "percent_of_net_assets": 4.6972, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Medpace Holdings Inc.", "issuer_lei": "549300H8TYEUVTW14A54", "security_title": "Medpace Holdings, Inc.", "cusip": "58506Q109", "isin": "US58506Q1094", "ticker": null, "balance": 3593.0, "units": "NS", "currency_code": "USD", "value_usd": 2092850.64, "percent_of_net_assets": 3.978, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Merck & Co., Inc", "issuer_lei": "4YV9Y5M8S0BRK1RP0397", "security_title": "Merck & Company, Inc.", "cusip": "58933Y105", "isin": "US58933Y1055", "ticker": null, "balance": 13629.0, "units": "NS", "currency_code": "USD", "value_usd": 1502869.83, "percent_of_net_assets": 2.8566, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "National Healthcare Corporation", "issuer_lei": "254900PTS11LS1JS2752", "security_title": "National HealthCare Corporation", "cusip": "635906100", "isin": "US6359061008", "ticker": null, "balance": 9612.0, "units": "NS", "currency_code": "USD", "value_usd": 1375573.32, "percent_of_net_assets": 2.6146, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Novartis AG", "issuer_lei": "5493007HIVTX6SY6XD66", "security_title": "Novartis A.G.", "cusip": "66987V109", "isin": "US66987V1098", "ticker": null, "balance": 16784.0, "units": "NS", "currency_code": "USD", "value_usd": 2495445.12, "percent_of_net_assets": 4.7433, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "CH", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Novo Nordisk A/S", "issuer_lei": "549300DAQ1CVT6CXN342", "security_title": "Novo Nordisk A/S", "cusip": "670100205", "isin": "US6701002056", "ticker": null, "balance": 19907.0, "units": "NS", "currency_code": "USD", "value_usd": 1183073.01, "percent_of_net_assets": 2.2487, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "DK", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Regeneron Pharmaceuticals, Inc.", "issuer_lei": "549300RCBFWIRX3HYQ56", "security_title": "Regeneron Pharmaceuticals, Inc.", "cusip": "75886F107", "isin": "US75886F1075", "ticker": null, "balance": 3260.0, "units": "NS", "currency_code": "USD", "value_usd": 2417127.0, "percent_of_net_assets": 4.5944, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Stryker Corporation", "issuer_lei": "5493002F0SC4JTBU5137", "security_title": "Stryker Corporation", "cusip": "863667101", "isin": "US8636671013", "ticker": null, "balance": 3396.0, "units": "NS", "currency_code": "USD", "value_usd": 1255025.76, "percent_of_net_assets": 2.3855, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Thermo Fisher Scientific Inc", "issuer_lei": "HCHV7422L5HDJZCRFL38", "security_title": "Thermo Fisher Scientific, Inc.", "cusip": "883556102", "isin": "US8835561023", "ticker": null, "balance": 3329.0, "units": "NS", "currency_code": "USD", "value_usd": 1926192.69, "percent_of_net_assets": 3.6612, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "United Therapeutics Corporation", "issuer_lei": "5299005C4HZL4UWROC14", "security_title": "United Therapeutics Corporation", "cusip": "91307C102", "isin": "US91307C1027", "ticker": null, "balance": 5543.0, "units": "NS", "currency_code": "USD", "value_usd": 2602383.07, "percent_of_net_assets": 4.9465, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Veeva Systems Inc", "issuer_lei": "549300YZEXPDB92M2F02", "security_title": "Veeva Systems, Inc.", "cusip": "922475108", "isin": "US9224751084", "ticker": null, "balance": 3441.0, "units": "NS", "currency_code": "USD", "value_usd": 701688.72, "percent_of_net_assets": 1.3337, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Vertex Pharmaceuticals Incorporated", "issuer_lei": "54930015RAQRRZ5ZGJ91", "security_title": "Vertex Pharmaceuticals, Inc.", "cusip": "92532F100", "isin": "US92532F1003", "ticker": null, "balance": 3831.0, "units": "NS", "currency_code": "USD", "value_usd": 1800186.9, "percent_of_net_assets": 3.4217, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Mount Vernon Liquid Assets Portfolio, LLC", "issuer_lei": "N/A", "security_title": "Mount Vernon Liquid Assets Portfolio, LLC", "cusip": "N/A", "isin": null, "ticker": null, "balance": 5747803.25, "units": "PA", "currency_code": "USD", "value_usd": 5747803.25, "percent_of_net_assets": 10.9252, "payoff_profile": "Long", "asset_category": "STIV", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "N/A"}, {"issuer_name": "Jazz Pharmaceuticals PLC", "issuer_lei": "635400GAUMJCLEZRRV50", "security_title": "Jazz Pharmaceuticals plc", "cusip": "G50871105", "isin": "IE00B4Q5ZN47", "ticker": null, "balance": 12812.0, "units": "NS", "currency_code": "USD", "value_usd": 2107445.88, "percent_of_net_assets": 4.0058, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "IE", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "Medtronic PLC", "issuer_lei": "549300GX3ZBSQWUXY261", "security_title": "Medtronic plc", "cusip": "G5960L103", "isin": "IE00BTN1Y115", "ticker": null, "balance": 12359.0, "units": "NS", "currency_code": "USD", "value_usd": 1272482.64, "percent_of_net_assets": 2.4187, "payoff_profile": "Long", "asset_category": "EC", "issuer_category": "CORP", "investment_country": "IE", "is_restricted": "N", "fair_value_level": "1"}, {"issuer_name": "N/A", "issuer_lei": "N/A", "security_title": "Prime Solutions 3.25% 2/2/26", "cusip": "N/A", "isin": null, "ticker": null, "balance": 188332.43, "units": "PA", "currency_code": "USD", "value_usd": 188332.43, "percent_of_net_assets": 0.358, "payoff_profile": "Long", "asset_category": "RA", "issuer_category": "CORP", "investment_country": "US", "is_restricted": "N", "fair_value_level": "N/A"}]}